InMed Pharmaceuticals Inc. (INM) Fundamentals

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.
SHARE INFORMATION
Market Cap$ 6,348,888
Shares Outstanding8,050,707
Float16,178,363
Percent Float99.46%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions23
Institutional Holdings Date2021-04-30
Institutional Bought Previous 3 Months11,200
Institutional Holdings Percent1.1%
Institutional Sold Previous 3 Months-
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.5
Insider Sold Previous 3 Months29,151
Insider Shares Owned401,916
TRADING INFO
52 Week High$ 2.64
52 Week Low$ 0.34
52 Week High Change$ -84.33
21 Day Moving Average$ 0.3962
21 Day Extended Moving Average$ 0.413914
50 Day Moving Average$ 0.4979
50 Day Extended Moving Average$ 0.504426
200 Day Moving Average$ 0.994224
200 Day Extended Moving Average$ 1.0734
10 Day Average Volume81,301
20 Day Average Volume356,401
30 Day Average Volume258,921
50 Day Average Volume199,254
Alpha-0.092570
Beta0.3031
Standard Deviation0.173959
R20.007116
7 Day Price Change$ 0.0098
7 Day Percent Change2.58%
21 Day Price Change$ 0.0167
21 Day Percent Change4.47%
30 Day Price Change$ -0.0947
30 Day Percent Change-19.53%
Month to Date Price Change$ 0.0003
Month to Date Percent Change0.08%
Quarter to Date Price Change$ -0.0801
Quarter to Date Percent Change-17.03%
180 Day Price Change$ -0.7897
180 Day Percent Change-66.92%
200 Day Price Change$ -0.8397
200 Day Percent Change-68.27%
Year to Date Price Change$ -0.9197
Year to Date Percent Change-70.21%

InMed Pharmaceuticals Inc. (INM) Key Ratios

PROFITABILITY
EBIT Margin-2,434.2%
EBITDA Margin-2,382.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin51.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 557,527
Revenue Per Share$ 0.0343
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.10
Total Debt To Equity0.10
Int Coverage-33.30
Current Ratio2.10
Leverage Ratio1.30
Quick Ratio1.50
Long Term Debt To Capital0.04
VALUATION MEASURES
PE Ratio-2.40
Enterprise Value$ 14,915,661
Price to Sales11.3876
Price to Free Cash-2.30
PE High Last 5 Years-2.60
Price To Book0.60
Price To Cash Flow9,081.60
PE Low Last 5 Years-5.00
Price to Tangible Book5.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover14.10
Invoice Turnover0.10
Assets Turnover0.00
Return Assets-103.08
Return on Equity-135.02
Return on Capital-124.84

InMed Pharmaceuticals Inc. (INM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOEric A. Adams
Emplyoees15
Last AuditUE
CIK0001728328
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address815 West Hastings Street
Suite 310
Vancouver, BC V6C 1B4
Websitehttp://www.inmedpharma.com
Facsimile+1 778 945-6800
Telephone+1 604 669-7207
Emailbcolwill@inmedpharma.com


Your Recent History
NASDAQ
INM
InMed Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.